Bionano Genomics, Inc. (BNGO)

Bionano Genomics Statistics

Total Valuation

BNGO has a market cap or net worth of $19.89 million. The enterprise value is $30.39 million.

Market Cap	19.89M
Enterprise Value	30.39M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

BNGO has 101.99 million shares outstanding. The number of shares has increased by 94.65% in one year.

Current Share Class	101.99M
Shares Outstanding	101.99M
Shares Change (YoY)	+94.65%
Shares Change (QoQ)	+27.06%
Owned by Insiders (%)	0.22%
Owned by Institutions (%)	4.82%
Float	101.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.36
Forward PS	0.69
PB Ratio	0.35
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.46.

Current Ratio	1.43
Quick Ratio	0.52
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.21

Financial Efficiency

Return on equity (ROE) is -161.77% and return on invested capital (ROIC) is -65.04%.

Return on Equity (ROE)	-161.77%
Return on Assets (ROA)	-48.42%
Return on Capital (ROIC)	-65.04%
Revenue Per Employee	$96,901
Profits Per Employee	-$394,718
Employee Count	344
Asset Turnover	0.25
Inventory Turnover	1.67

Taxes

Income Tax	-4,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.96% in the last 52 weeks. The beta is 2.26, so BNGO's price volatility has been higher than the market average.

Beta (5Y)	2.26
52-Week Price Change	-87.96%
50-Day Moving Average	0.27
200-Day Moving Average	0.62
Relative Strength Index (RSI)	31.09
Average Volume (20 Days)	3,010,328

Short Selling Information

The latest short interest is 12.66 million, so 12.41% of the outstanding shares have been sold short.

Short Interest	12.66M
Short Previous Month	12.11M
Short % of Shares Out	12.41%
Short % of Float	12.44%
Short Ratio (days to cover)	3.81

Income Statement

In the last 12 months, BNGO had revenue of $33.33 million and -$135.78 million in losses. Loss per share was -$2.21.

Revenue	33.33M
Gross Profit	-599,000
Operating Income	-104.31M
Pretax Income	-204.09M
Net Income	-135.78M
EBITDA	-89.09M
EBIT	-104.31M
Loss Per Share	-$2.21

Balance Sheet

The company has $11.95 million in cash and $22.45 million in debt, giving a net cash position of -$10.50 million or -$0.10 per share.

Cash & Cash Equivalents	11.95M
Total Debt	22.45M
Net Cash	-10.50M
Net Cash Per Share	-$0.10
Equity (Book Value)	48.87M
Book Value Per Share	0.55
Working Capital	14.03M

Cash Flow

In the last 12 months, operating cash flow was -$92.20 million and capital expenditures -$848,000, giving a free cash flow of -$93.05 million.

Operating Cash Flow	-92.20M
Capital Expenditures	-848,000
Free Cash Flow	-93.05M
FCF Per Share	-$0.91

Margins

Gross Margin	-1.80%
Operating Margin	-312.92%
Pretax Margin	-407.35%
Profit Margin	n/a
EBITDA Margin	-267.26%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BNGO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-94.65%
Shareholder Yield	-94.65%
Earnings Yield	-682.72%
FCF Yield	-467.83%

Analyst Forecast

The average price target for BNGO is $1.00, which is 412.82% higher than the current price. The consensus rating is "Hold".

Price Target	$1.00
Price Target Difference	412.82%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	32.21%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 7, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Aug 7, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

BNGO has an Altman Z-Score of -13.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.29
Piotroski F-Score	2